Type your tag names separated by a space and hit enter

Primary Lateral Sclerosis

Primary Lateral Sclerosis is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

  • Primary lateral sclerosis (PLS) is a rare progressive degenerative disease of the corticospinal and corticobulbar tracts (upper motor neurons [UMNs]), which spares the anterior horn cells.
  • Characterized by leg weakness, spasticity, and bulbar symptoms like dysphagia and dysarthria
  • Additional features include cognitive impairment, eye movement abnormalities, and urinary dysfunction.
  • Part of the spectrum of motor neuron diseases (MNDs) because some patients with PLS evolve to develop amyotrophic lateral sclerosis (ALS)
  • Conversion from PLS to ALS has been reported up to 27 years after the onset of spasticity.

Epidemiology

  • Found in 1–3% of patients with motor neuron disorder
  • Onset is usually after age 40 years, although a juvenile form has been described.
  • Mean age at symptom onset is 54 years.
  • There is a slight male predominance, which is similar to ALS.

Incidence
Incidence is difficult to determine due to rarity, misdiagnosis, and changing diagnosis. An estimated 1/10 million/year or 300 to 500 people in the United States are diagnosed yearly.

Prevalence
Estimated prevalence is 10 to 20/million.

Etiology and Pathophysiology

PLS is usually sporadic with no known cause; potential role of TAR DNA–binding protein 43 (TDP-43) (1)


Genetics
  • Juvenile PLS and juvenile ALS has been correlated with a mutation in the ALS2 gene on chromosome 2. It is inherited in an autosomal recessive pattern.
  • Mutation of the ERLIN2 gene, a component of the endoplasmic reticulum lipid raft has been linked to juvenile PLS.

General Prevention

There is no known means of prevention.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Stephens, Mark B., et al., editors. "Primary Lateral Sclerosis." 5-Minute Clinical Consult, 27th ed., Wolters Kluwer, 2019. Medicine Central, im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816019/all/Primary_Lateral_Sclerosis.
Primary Lateral Sclerosis. In: Stephens MB, Golding J, Baldor RA, et al, eds. 5-Minute Clinical Consult. 27th ed. Wolters Kluwer; 2019. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816019/all/Primary_Lateral_Sclerosis. Accessed April 18, 2019.
Primary Lateral Sclerosis. (2019). In Stephens, M. B., Golding, J., Baldor, R. A., & Domino, F. J. (Eds.), 5-Minute Clinical Consult. Available from https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816019/all/Primary_Lateral_Sclerosis
Primary Lateral Sclerosis [Internet]. In: Stephens MB, Golding J, Baldor RA, Domino FJ, editors. 5-Minute Clinical Consult. Wolters Kluwer; 2019. [cited 2019 April 18]. Available from: https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816019/all/Primary_Lateral_Sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Primary Lateral Sclerosis ID - 816019 ED - Stephens,Mark B, ED - Golding,Jeremy, ED - Baldor,Robert A, ED - Domino,Frank J, BT - 5-Minute Clinical Consult, Updating UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816019/all/Primary_Lateral_Sclerosis PB - Wolters Kluwer ET - 27 DB - Medicine Central DP - Unbound Medicine ER -